Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Dexcom (DXCM) over the last 14 years, with Q4 2025 value amounting to $3.8 million.

  • Dexcom's Exchange Rate Effect rose 13392.86% to $3.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $21.5 million, marking a year-over-year increase of 39054.05%. This contributed to the annual value of $21.5 million for FY2025, which is 39054.05% up from last year.
  • As of Q4 2025, Dexcom's Exchange Rate Effect stood at $3.8 million, which was up 13392.86% from -$1.1 million recorded in Q3 2025.
  • Over the past 5 years, Dexcom's Exchange Rate Effect peaked at $16.5 million during Q2 2025, and registered a low of -$11.2 million during Q4 2024.
  • Over the past 5 years, Dexcom's median Exchange Rate Effect value was -$750000.0 (recorded in 2021), while the average stood at $420000.0.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first crashed by 96000.0% in 2022, then surged by 175000.0% in 2025.
  • Over the past 5 years, Dexcom's Exchange Rate Effect (Quarter) stood at -$500000.0 in 2021, then soared by 1460.0% to $6.8 million in 2022, then dropped by 10.29% to $6.1 million in 2023, then crashed by 283.61% to -$11.2 million in 2024, then skyrocketed by 133.93% to $3.8 million in 2025.
  • Its Exchange Rate Effect stands at $3.8 million for Q4 2025, versus -$1.1 million for Q3 2025 and $16.5 million for Q2 2025.